Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,273.00
-22.00 (-1.70%)
Mar 27, 2025, 5:30 PM IDT
-5.49%
Market Cap 146.22M
Revenue (ttm) 331.60M
Net Income (ttm) 7.63M
Shares Out 11.41M
EPS (ttm) 0.68
PE Ratio 18.97
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,413
Average Volume 1,255
Open 1,295.00
Previous Close 1,295.00
Day's Range 1,273.00 - 1,341.00
52-Week Range 1,167.00 - 1,601.00
Beta 0.05
RSI 16.73
Earnings Date Mar 27, 2025

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in... [Read more]

Sector Healthcare
Founded 1947
Employees 427
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

In 2023, TLV:REKA's revenue was 321.66 million, an increase of 10.01% compared to the previous year's 292.39 million. Losses were -6.91 million, 238.6% more than in 2022.

Financial Statements

News

There is no news available yet.